columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - Антинеопластични средства - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.
grimodin 100 mg capsules, hard
egis pharmaceuticals plc - Габапентин - 100 mg capsules, hard
grimodin 300 mg hard capsules
egis pharmaceuticals plc - Габапентин - 300 mg hard capsules
grimodin 400 mg hard capsules
egis pharmaceuticals plc - Габапентин - 400 mg hard capsules
noflamen 7,5 mg tablets
egis pharmaceuticals public limited company - Мелоксикам - 7,5 mg tablets
noflamen 15 mg tablets
egis pharmaceuticals public limited company - Мелоксикам - 15 mg tablets
egilok succ 23,75 mg prolonged - release tablets
egis pharmaceuticals plc - Метопролол - 23,75 mg prolonged - release tablets
egilok succ 47,5 mg prolonged - release tablets
egis pharmaceuticals plc - Метопролол - 47,5 mg prolonged - release tablets
egilok succ 95 mg prolonged - release tablets
egis pharmaceuticals plc - Метопролол - 95 mg prolonged - release tablets
egilok succ 190 mg prolonged - release tablets
egis pharmaceuticals plc - Метопролол - 190 mg prolonged - release tablets